Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-23-020185
Filing Date
2023-04-25
Accepted
2023-04-25 16:02:07
Documents
9
Period of Report
2023-06-09

Document Format Files

Seq Description Document Type Size
1 DEF 14A ny20007145x2_def14a.htm DEF 14A 1486901
2 ny20007145x2_barchart01.jpg GRAPHIC 100862
3 ny20007145x2_barchart02.jpg GRAPHIC 137359
4 ny20007145x2_barchart03.jpg GRAPHIC 127458
5 ny20007145x2_pc01.jpg GRAPHIC 681059
6 ny20007145x2_pc02.jpg GRAPHIC 638417
7 ny20007145x2_piechart01.jpg GRAPHIC 91888
8 ny20007145x2_piechart02.jpg GRAPHIC 80638
9 ny20007145x2_piechart03.jpg GRAPHIC 56918
  Complete submission text file 0001140361-23-020185.txt   4123237
Mailing Address 100 CARDINAL WAY REDWOOD CITY CA 94063
Business Address 100 CARDINAL WAY REDWOOD CITY CA 94063 (650) 649-1004
Adverum Biotechnologies, Inc. (Filer) CIK: 0001501756 (see all company filings)

EIN.: 205258327 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36579 | Film No.: 23844783
SIC: 2836 Biological Products, (No Diagnostic Substances)